While the success rate of process development services for AAV manufacturing is highly dependent on the plasmid vector, the transgene especially its size, the AAV serotype, the cell line, and medium, Celvab can not guarantee 100% success rate, our in-house data show a success rate greater than 90%.
Fast turnaround of process development services for AAV manufacturing: 6-7 months.
We have a lot of experience in dealing with difficult-to-manufacture AAV.